• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Experts sound the alarm over ‘shocking’ study showing significant risks to women who take abortion pills

by May 6, 2025
written by May 6, 2025

A new study exposing a significant number of ‘serious adverse events’ occurring among women who have taken mifepristone, also known as the ‘abortion pill,’ has sparked an outcry from the pro-life community, including experts who spoke to Fox News Digital about what the study means for women in the United States. 

‘The biggest thing that will shock most readers of this report is just how different the findings in this study are from what the FDA claims on the abortion drug label,’ Katie Glenn Daniel, SBA Pro Life America director of legal affairs, told Fox News Digital about the recently released study. 

‘What they found is that more than one in ten women will go to the emergency room seeking follow-up care after taking the abortion drugs. The FDA claims that’s more like one in 20 women, which is still concerning, right? If you’ve got a one in twenty chance of something happening, you might take that seriously, but one in 10. It is shocking,’ she continued. ‘This means hundreds of thousands of American women have gone to the hospital for complications from abortions through these abortion drugs and the FDA was not collecting information about those situations. So this study shines a light on what has been happening, what ER doctors certainly know is happening. But what our public health institutions have turned a blind eye to.’

Mifepristone is a ‘pregnancy blocker’ that is used in combination with another medication, misoprostol, to terminate pregnancies, according to Mayo Clinic. It is also used to manage early miscarriages, as it helps prepare the body to empty the uterus.

Research by the Ethics & Public Policy Center in Washington, D.C., has revealed that the rate of serious side effects is 22 times higher than what is indicated on the FDA-approved drug label.

After going through an abortion assisted by mifepristone, nearly 11% of women — more than one in 10 — reported experiencing ‘infection, hemorrhaging, or another serious or life-threatening adverse event,’ according to the study summary.

‘These reports, which analyzed the largest known data set of real-world mifepristone use, confirm what physicians like me and our members are seeing in our clinical practice: that abortion drugs pose significant dangers to women,’ Dr. Christina Francis, a board-certified OB/GYN, told Fox News Digital. 

‘I have had patients face life-threatening hemorrhage, infection, and more after taking these drugs, which are now available to order online without an in-person physician visit to confirm the age of the pregnancy and rule out risk factors. The fact that these data show a serious complication rate that is 22 times higher than what the FDA states reveals the urgent need for further investigation into complications of drug-induced abortions and for policymakers and agencies to reprioritize women’s safety over the interests of the abortion industry. Women and their children deserve better care than these dangerous drugs.’

Mifepristone, which the Biden administration took steps to ensure was made available to women through the mail, is the most well-known abortion pill in the United States, and approximately 63% of all abortions in the U.S. in 2023 were medication abortions, according to the Guttmacher Institute. 

This was an increase from 53% in 2020.

We knew that the Biden administration’s changes to the abortion drug prescribing, which included allowing these drugs to be sent through to mail. We knew that that was harmful for women and girls because there is no medical oversight,’ Daniel told Fox News Digital. ‘You don’t even know if a pregnant woman’s getting these drugs. There have been cases where men order these drugs, to slip them to somebody. The state of Louisiana has a case right now where a mother ordered them and forced her daughter to take them, even though the pregnancy was wanted. So you really lose a lot of the safeguards that are in place when somebody actually physically goes to a doctor’s office.’

Daniel told Fox News Digital she hopes this report will encourage the Trump administration’s FDA to take action to ensure that women and unborn children are protected. 

A drug that puts one in ten women in the hospital is certainly not a drug that is quote unquote good for women or caring for women and I think we need to be realistic about that,’ Daniel said. 

Daniel also explained that the true harm from the pill is likely even worse than the study only includes certain years and only women who used insurance.

‘So there are tons of women, including those who are the most vulnerable, who are left out of this data,’ Daniel pointed out. 

‘There is a lot more to look out here,’ Daniel continued. ‘We see this as the starting point of what the FDA, the CDC, our public health institutions, and our physicians need to be looking at. And we need to have an honest conversation about the fact that 20 years of data shows that these drugs are deadly for children, but they’re also very dangerous for in girls.’

Fox News Digital’s Melissa Rudy contributed to this report

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
German conservative’s bid for chancellor falls short, a first in more than 75 years
next post
Supreme Court flare-ups grab headlines as justices feel the heat

related articles

Senate sends $901B defense bill to Trump after...

December 17, 2025

Four Republicans buck Mike Johnson to join Hakeem...

December 17, 2025

House Republican who voted to impeach Trump in...

December 17, 2025

EXCLUSIVE: First look at ‘MELANIA’ film

December 17, 2025

Trump’s push to ‘knock out’ filibuster gains new...

December 17, 2025

Policy group praises Trump’s 100 global wins since...

December 17, 2025

Trump declares ‘Venezuelan regime’ a foreign terrorist organization,...

December 17, 2025

Judge warns Trump administration against ‘irreversible’ White House...

December 17, 2025

The Hitchhiker’s Guide to where we stand with...

December 17, 2025

Senate Republican ‘targeted by Communist China’ in $50...

December 17, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Republicans urge Trump to follow through on his plan to dismantle Iran’s nuclear capabilities

    May 14, 2025
  • Democrat Congresswoman draws boos over ‘shameful’ sexism remark in committee hearing with Treasury Secretary

    June 12, 2025
  • White House rips alleged Pentagon leakers’ ‘shattered egos,’ brushes off Hegseth second Signal chat report

    April 21, 2025
  • What Virginia’s special elections tell us about the bigger ballot box battles to come in 2025, 2026

    January 8, 2025
  • White House rejects ‘blank checks’ for Ukraine, presses NATO to shoulder costs

    August 19, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (7,104)
  • Investing (705)
  • Stock (963)

Latest Posts

  • Trump, eyeing 3rd term, keeps attacking elite institutions – and many are caving

    April 1, 2025
  • Blinken questioned for State Department hosting in-house therapy sessions after Trump win

    November 24, 2024
  • Graham says Trump wants to ‘move the bill’ on Russia sanctions, but procedural hurdles await

    November 22, 2025

Recent Posts

  • Who could run to replace Stefanik in the House?

    November 12, 2024
  • Mortgage rates plunge to the lowest level in over a year after weak employment report

    August 5, 2024
  • Trump’s week in review: President secures historic peace deal to bring hostages home as shutdown continues

    October 11, 2025

Editor’s Pick

  • Trump wants to visit China again after he takes office: report

    January 19, 2025
  • House leaders move quickly to consolidate power in show of confidence for Republican majority

    November 7, 2024
  • Ahead of Trump admin-Iran talks, new report says Iran nuclear threat rises to ‘extreme danger’

    April 10, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock